Pediatrix Medical Group, Inc. (MD)
NYSE: MD · Real-Time Price · USD
26.86
+0.72 (2.75%)
Jul 28, 2026, 4:00 PM EDT - Market closed
Pediatrix Medical Group Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,932 | 1,914 | 2,013 | 1,995 | 1,972 | 1,911 | |
Revenue Growth | -2.25% | -4.92% | 0.92% | 1.15% | 3.18% | 10.22% |
Cost of Revenue | 1,428 | 1,420 | 1,559 | 1,573 | 1,505 | 1,398 |
Gross Profit | 504.03 | 493.7 | 454.34 | 421.57 | 467.03 | 513.24 |
Selling, General & Admin | 242.45 | 240.79 | 238.44 | 227.54 | 231.4 | 263.36 |
Depreciation & Amortization Expenses | 22.61 | 21.83 | 32.23 | 36.17 | 35.64 | 32.15 |
Other Operating Expenses | 20.59 | 22.27 | 252.39 | 150.53 | 27.31 | 0.29 |
Total Operating Expenses | 285.66 | 284.89 | 523.06 | 414.24 | 294.35 | 295.79 |
Operating Income | 218.37 | 208.81 | -68.71 | 7.32 | 172.69 | 217.45 |
Interest Income | 22.99 | 43.58 | 8.12 | 6.4 | 5.39 | 15.56 |
Interest Expense | -35.08 | -35.97 | -40.74 | -42.08 | -39.7 | -68.72 |
Other Non-Operating Income (Expense) | - | - | - | -20 | -57.02 | 1.91 |
Total Non-Operating Income (Expense) | -12.09 | 7.62 | -32.63 | -55.68 | -91.32 | -51.25 |
Pretax Income | 206.28 | 216.43 | -101.34 | -48.36 | 81.37 | 166.2 |
Provision for Income Taxes | 52.96 | 51.04 | -2.27 | 12.05 | 18.81 | 27.24 |
Net Income | 174.22 | 165.39 | -99.07 | -60.41 | 66.33 | 130.94 |
Minority Interest in Earnings | - | - | - | - | 0 | 0.03 |
Earnings From Discontinued Operations | - | - | - | - | 3.77 | 22.95 |
Net Income to Common | 174.22 | 165.39 | -99.07 | -60.41 | 66.34 | 130.96 |
Net Income Growth | - | - | - | - | -49.35% | - |
Shares Outstanding (Basic) | 84 | 84 | 83 | 82 | 83 | 85 |
Shares Outstanding (Diluted) | 85 | 85 | 83 | 82 | 84 | 86 |
Shares Change | 0.06% | 2.33% | 1.37% | -2.28% | -1.99% | 2.92% |
EPS (Basic) | 2.08 | 1.97 | -1.19 | -0.73 | 0.75 | 1.54 |
EPS (Diluted) | 2.06 | 1.94 | -1.19 | -0.73 | 0.74 | 1.53 |
EPS Growth | - | - | - | - | -51.63% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 237.32 | 252.63 | 184.55 | 104 | 137.23 | 44.49 |
Free Cash Flow Growth | 22.13% | 36.89% | 77.46% | -24.22% | 208.46% | -74.70% |
Free Cash Flow Per Share | 2.80 | 2.96 | 2.21 | 1.27 | 1.63 | 0.52 |
Gross Margin | 26.09% | 25.80% | 22.57% | 21.13% | 23.68% | 26.85% |
Operating Margin | 11.30% | 10.91% | -3.41% | 0.37% | 8.76% | 11.38% |
Profit Margin | 9.02% | 8.64% | -4.92% | -3.03% | 3.36% | 6.85% |
FCF Margin | 12.29% | 13.20% | 9.17% | 5.21% | 6.96% | 2.33% |
EBITDA | 240.98 | 230.64 | -36.49 | 43.49 | 208.32 | 249.6 |
EBITDA Margin | 12.48% | 12.05% | -1.81% | 2.18% | 10.56% | 13.06% |
EBIT | 218.37 | 208.81 | -68.71 | 7.32 | 172.69 | 217.45 |
EBIT Margin | 11.30% | 10.91% | -3.41% | 0.37% | 8.76% | 11.38% |
Effective Tax Rate | 25.68% | 23.58% | 2.24% | -24.92% | 23.11% | 16.39% |